Diabetic Peripheral Neuropathy

Recruiting for Study: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain

Erchonia Corporation is currently recruiting for a study on the effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy pain. This study can be found at ClinicalTrials.gov here. PURPOSE OF THE STUDY In this study, the Sponsor, Erchonia Corporation, and investigators are studying the use of a device called the Erchonia® FX-635™ that gives …

Recruiting for Study: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain Read More »

diabetic peripheral neuropathy treatment

Research Study for Painful Diabetic Peripheral Neuropathy

Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy. Aptinyx Inc. is conducting a research study evaluating multiple doses of its investigational drug NYX-2925 versus placebo in treating the neuropathic pain associated with diabetic peripheral neuropathy. Enrollment into this …

Research Study for Painful Diabetic Peripheral Neuropathy Read More »

Clinical Trial

Clinical Trial for Diabetic Peripheral Neuropathy

Northwestern University is conducting a Phase III clinical trial with Viromed Pharmaceuticals for an investigational drug (VM202) on painful, diabetic peripheral neuropathy in the legs and feet. This drug has been shown to be safe and effective at reducing pain caused by neuropathy through the generation of new blood vessels and nerves. The basic inclusion/exclusion …

Clinical Trial for Diabetic Peripheral Neuropathy Read More »

diabetic peripheral neuropathy treatment

Treating Painful Diabetic Peripheral Neuropathy: An Update

Summary of journal article reviewing the current state of diabetic peripheral neuropathy treatment: Painful diabetic peripheral neuropathy occurs in approximately 25% of patients with diabetes mellitus who are treated in the office setting and significantly affects quality of life. It typically causes burning pain, paresthesias, and numbness in a stocking-glove pattern that progresses proximally from …

Treating Painful Diabetic Peripheral Neuropathy: An Update Read More »

diabetic peripheral neuropathy

Underlying Cause of Diabetic Peripheral Neuropathy Targeted in Gene Therapy Trial

VM BioPharma, the United States division of ViroMed Co., Ltd. in Seoul, Korea, announced the first patient was dosed in the recently initiated Phase 3 clinical study evaluating VM202, a proprietary DNA-based biopharmaceutical, in patients with painful diabetic peripheral neuropathy (DPN). This is the first pivotal gene therapy trial specifically targeting the most common cause …

Underlying Cause of Diabetic Peripheral Neuropathy Targeted in Gene Therapy Trial Read More »

Small Nerve Fibers Defy Neuropathy Conventions

Peripheral neuropathy research study suggests even prediabetes could cause nerve damage. Peripheral neuropathy research results of a small study of people with tingling pain in their hands and feet have added to evidence that so-called prediabetes is more damaging to motor nerves than once believed. The report on the study was published online in JAMA …

Small Nerve Fibers Defy Neuropathy Conventions Read More »

FPN Connects Peripheral Neuropathy Researchers at Astellas Pharma to the Patients They Are Hoping to Serve

On December 3, 2015, Astellas Pharma US, Inc. (the U.S. affiliate of Astellas Pharma Inc.), a R&D-driven global pharmaceutical company, invited the Foundation for Peripheral Neuropathy to present to a global team working on development of ASP3662 for patients with neuropathic pain (NP). This was an internal meeting, which included Ulf Tollemar, Executive Director, Development …

FPN Connects Peripheral Neuropathy Researchers at Astellas Pharma to the Patients They Are Hoping to Serve Read More »

New Findings Point to Central Nervous System Role in Painful Diabetic Peripheral Neuropathy

Emerging evidence suggests that the central nervous system (CNS) is a key contributor to the problem of painful peripheral nerve disease in people with diabetes, according to a special article in the February issue of Pain, the official publication of the International Association for the Study of Pain (IASP).  READ MORE Source: MedicalPress

Stem Cells Show Promise as Treatment for Diabetic Neuropathy

Research released earlier this summer shows that rats who received intra-muscular injections of mesenchymal stem cells (MSC’s are adult stem cells traditionally found in the bone marrow. but can also be isolated from other tissues including cord blood, peripheral blood, fallopian tube, and fetal liver and lung) 12 weeks after the induction of diabetes offered …

Stem Cells Show Promise as Treatment for Diabetic Neuropathy Read More »

Efficacy and Safety of Qutenzatm (8% Capsaicin Patch)

Neuropathy is one of the most common long-term complications of diabetes mellitus (DM) and painful neuropathy can be challenging to treat. There is no consensus on optimal treatment and many current therapies are limited by their tolerability, the need for titration, drug-drug interactions, administration of multiple daily doses, or the invasive nature of surgical procedures …

Efficacy and Safety of Qutenzatm (8% Capsaicin Patch) Read More »

Send this to a friend